Profusa Issues $769K Senior Secured Convertible Note to Ascent Partners, Raising $700K at 7%
Profusa issued a $769K senior secured convertible note to Ascent Partners, raising $700K at 7% interest. The note matures by Oct. 15, 2027, or upon an option closing, and is convertible at $4.28 per share. The deal aims to enhance liquidity and provide conversion flexibility, according to the company.
How this was made
The 30-second read
Why it matters
The financing improves short‑term liquidity but introduces potential dilution, likely exerting slight downward pressure on the stock.
Market read
A micro‑cap financing event with modest dollar size; relevance primarily to PFSA shareholders and niche biotech investors.
What to watch
Conversion price $4.28 and floor $1.07 may become attractive if the stock rallies.
Background
Profusa (PFSA) disclosed a senior secured convertible promissory note issuance to Ascent Partners Fund, raising $700K with a 7% interest rate and conversion terms.
Ticker impact
Profusa issued a $769K senior secured convertible note raising $700K, a fresh capital‑raise disclosed in an 8‑K filing.
likely modest pressure as the market prices in the dilution risk
Micro‑cap financing of this size typically has limited upside and may be viewed as a short‑term dilution event.
Market effects
Minimal impact on the broader biotech financing landscape.
Limited to US micro‑cap investors.
Low
Counterpoint
The note could provide needed runway for upcoming trials, supporting a longer‑term upside.
Key entities
- companyProfusa, Inc.
Biotech firm issuing the convertible note.
- investorAscent Partners Fund
Counterparty receiving the note.